Roche Tries Again With Failed Huntington’s Drug Tominersen

Potential In Younger Adults

 
• By Andrew McConaghie
  
Roche
Roche is committed to pursuing neurodegeneration diseases - despite the current high level of failure in the field. • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Rare Diseases

More from Scrip